Value Forum
MNV
Market News Video
MNV MNV Follow marketnewsvideo on Twitter
  Stock AlertsFree email alerts when your stocks are mentioned in videos
MNV
MNV
MNV
MNV
Analyst News Dividend Report Economic News Insider Report Large Caps Market Movers Week Ahead Report Weekly Market Wrap
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

ETFs Hold About $4.5 billion of Johnson & Johnson
Tuesday, October 5, 7:50 AM ET, by Market News Video Staff
ETFChannel.com's "ETF Components" toplist shows that aggregately ETFs hold nearly $4.5 billion of Johnson & ...

ETFs Hold More Than $3.2 Billion of Pfizer
Friday, October 8, 7:51 AM ET, by Market News Video Staff
According to ETFChannel.com's Top ETF Stock Components list, ETFs hold over $3.2 billion of Pfizer ...

EEN at Discount to NAV, Largest Holding Crucell N.V. ADR
Friday, October 8, 8:07 AM ET, by Market News Video Staff
The Guggenheim EW Euro-Pacific LDRs ETF (EEN) - formerly the Claymore/BNY Mellon EW Euro-Pac LDRs ...

Morgan Stanley Grows More Bullish on JNJ
Wednesday, October 20, 11:41 AM ET, by Market News Video Staff
This morning, Morgan Stanley raised its EPS estimates on shares of Johnson & Johnson (JNJ) ...

ETFs Impacted by Merck Results on Friday Morning
Friday, October 29, 9:22 AM ET, by Market News Video Staff
This morning, Merck (MRK) announced third quarter earnings of 85 cents per share, ex-items, narrowly ...

  More articles:  1 2 3 4 5 6 7 next »

JNJ Ordered to Pay $130M to Swiss Basilea

By Market News Video Staff, Monday, November 29, 12:44 PM ET

Johnson & Johnson (NYSE:JNJ) shares are falling today after it was ordered to pay $130 million to former partner Basilea.

A Dutch arbitration panel rule J&J must pay the Swiss firm for a breach of the two companies’ licensing agreement for the antibiotic ceftobiprole.

J&J ended its deal with Basilea after European and U.S. regulators did not approve the drug.

Johnson & Johnson ran the trials for the drug, which regulators deemed insufficient, resulting in the reject of the drug, Basilea argued.

Johnson & Johnson shares are trading down 1.15% Monday.

J&J is the top holding in the Pharmaceutical HOLDRS (AMEX:PPH) fund, at 25.79% of the portfolio.

Pfizer (NYSE:PFE) is the second-largest holding, at 18.16% of the fund, followed by Merck (NYSE:MRK), at 16.48% of the portfolio.

Abbott Laboratories (NYSE:ABT) is 10.33% of the total, while Bristol-Myers Squibb (BMY) is 7.23% of the fund.

Find the right mix of model portfolios today at PortfolioChannel.com

Top Six Most Viewed Stories This Hour @ Market News Video:
TBT, ACWV: Big ETF InflowsTBT, ACWV: Big ETF Inflows
Channel: ETFs Channel
Related symbols: TBT,ACWV 		Week Ahead Market Report: May 21, 2012Week Ahead Market Report: May 21, 2012
Channel: Week Ahead Report
Related symbols: BBY,BIG,FLO,CRMT,TNP 		Monday 5/21 Insider Buying Report: PAA, HEKMonday 5/21 Insider Buying Report: PAA, HEK
Channel:
Related symbols: PAA,HEK
Monday Sector Leaders: Precious Metals, Auto PartsMonday Sector Leaders: Precious Metals, Auto Parts
Channel: Market Movers
Related symbols: EGI,XG,SORL,AXL 		Monday Sector Laggards: Agriculture & Farm Products, Food StocksMonday Sector Laggards: Agriculture & Farm Products, Food Stocks
Channel: Market Movers
Related symbols: GRO,CRESY,ADY,CPB 		Learn About The 200 Day Moving AverageLearn About The 200 Day Moving Average
Channel:
Related symbols: SPY
This Article's Word Cloud:   AMEX   Abbott   Basilea   Bristol   Dutch   Johnson   Laboratories   Monday   Myers   NYSE   Pfizer   Pharmaceutical   Squibb   Swiss   after   agreement   antibiotic   approve   arbitration   argued   ceftobiprole   companies   deal   deemed   down   drug   falling   firm   followed   former   fund   holding   largest   licensing   million   ordered   panel   portfolio   regulators   reject   resulting   rule   second   shares   today   trading   trials   which   while   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use & Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Follow marketnewsvideo on Twitter
  Stock AlertsFree email alerts when your stocks are mentioned in videos
MNV

JNJ Ordered to Pay $130M to Swiss Basilea | Market News Video | Copyright © 2008 - 2012, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.